GlassScriptPhysician profile
Hassan Kamran
NPI 1871903484
$14,487.68
in general payments reported to CMS, 2019-2025
38 companies · $1,938 in 2025
The $1,938 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,746 · 2020: $2,692 · 2021: $2,887 · 2022: $1,521 · 2023: $1,379 · 2024: $2,323 · 2025: $1,938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,640.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,258.89 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Aveir |
| Boston Scientific Corporation | $1,712.87 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Bodyguardian |
| Edwards Lifesciences Corporation | $1,266.09 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $886.26 | 2022-2023 | Optimizer |
| Angiodynamics, INC. | $701.28 | 2024-2025 | Alphavac |
| Astrazeneca Pharmaceuticals LP | $308.44 | 2019-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $298.53 | 2021-2024 | Lifevest |
| Biosense Webster, INC. | $293.44 | 2024 | Carto 3 |
| Amgen INC. | $288.76 | 2019-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $240.44 | 2019-2025 | |
| Heartflow, INC. | $204.73 | 2025 | |
| Medtronic, INC. | $195.61 | 2021-2022 | |
| Cvrx, INC. | $184.13 | 2024-2025 | Barostim Neo System |
| Inari Medical, INC. | $181.65 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $163.55 | 2019-2024 | Xarelto |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hassan Kamran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.